(VIANEWS) – Catalyst Pharmaceuticals (CPRX), Webster Financial Corporation (WBS), Installed Building Products (IBP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Catalyst Pharmaceuticals (CPRX)
73.5% sales growth and 28.55% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.71.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.55. Meaning, the purchaser of the share is investing $21.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.55%.
Moving Average
Catalyst Pharmaceuticals’s value is way below its 50-day moving average of $17.45 and way higher than its 200-day moving average of $12.87.
Sales Growth
Catalyst Pharmaceuticals’s sales growth is 51.6% for the current quarter and 73.5% for the next.
2. Webster Financial Corporation (WBS)
51.5% sales growth and 9.11% return on equity
Webster Financial Corporation operates as the bank holding company for Webster Bank, National Association that provides a range of banking, investment, and financial services to individuals, families, and businesses in the United States. It operates through three segments: Commercial Banking, HSA Bank, and Community Banking. The Commercial Banking segment provides lending, deposit, and cash management services to middle market companies; and commercial and industrial lending and leasing, commercial real estate lending, equipment financing, and asset-based lending, as well as treasury and payment services. This segment also offers asset management, financial planning and trust services, and deposit and loan products for high net worth clients, not-for-profit organizations, and business clients. The HSA Bank segment offers health savings accounts, health reimbursement accounts, flexible spending accounts, and other financial solutions to employers for the benefit of their employees and individuals. The Community Banking segment offers deposit and fee-based services, residential mortgages, home equity lines or loans, unsecured consumer loans, and credit cards to consumers, as well as investment and securities-related services, including brokerage and investment advice through a strategic partnership with LPL Financial Holdings Inc. This segment also provides credit, deposit, and cash flow management products to businesses and professional service firms. The company also offers online and mobile banking services. As of February 12, 2021, it operated 155 banking centers and 297 ATMs. Webster Financial Corporation was founded in 1935 and is headquartered in Waterbury, Connecticut.
Earnings Per Share
As for profitability, Webster Financial Corporation has a trailing twelve months EPS of $3.13.
PE Ratio
Webster Financial Corporation has a trailing twelve months price to earnings ratio of 17.58. Meaning, the purchaser of the share is investing $17.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.11%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 2, 2022, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 3.03%.
Yearly Top and Bottom Value
Webster Financial Corporation’s stock is valued at $55.09 at 05:22 EST, way under its 52-week high of $63.23 and way above its 52-week low of $40.72.
3. Installed Building Products (IBP)
13.3% sales growth and 43.3% return on equity
Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States. The company offers a range of insulation materials, such as fiberglass and cellulose, and spray foam insulation materials. It is also involved in the installation of insulation and sealant materials in various areas of a structure, which includes basement and crawl space, building envelope, attic, and acoustical applications. In addition, the company installs a range of caulk and sealant products that control air infiltration in residential and commercial buildings; and waterproofing options, including sheet and hot applied waterproofing membranes, as well as deck coating, bentonite, and air and vapor systems. It serves homebuilders, multi-family and commercial construction firms, individual homeowners, and repair and remodeling contractors through a network of approximately 210 branch locations. The company was formerly known as CCIB Holdco, Inc. Installed Building Products, Inc. was founded in 1977 and is based in Columbus, Ohio.
Earnings Per Share
As for profitability, Installed Building Products has a trailing twelve months EPS of $6.32.
PE Ratio
Installed Building Products has a trailing twelve months price to earnings ratio of 17.37. Meaning, the purchaser of the share is investing $17.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.3%.
Volume
Today’s last reported volume for Installed Building Products is 264698 which is 32.89% above its average volume of 199180.
Sales Growth
Installed Building Products’s sales growth is 27% for the present quarter and 13.3% for the next.
Moving Average
Installed Building Products’s value is way higher than its 50-day moving average of $99.15 and way higher than its 200-day moving average of $90.99.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 13, 2022, the estimated forward annual dividend rate is 1.26 and the estimated forward annual dividend yield is 1.15%.
4. Surgery Partners (SGRY)
11.8% sales growth and 4.95% return on equity
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Earnings Per Share
As for profitability, Surgery Partners has a trailing twelve months EPS of $-3.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.95%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11%, now sitting on 2.44B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 21.7% and positive 166.7% for the next.
5. Broadcom (AVGO)
6% sales growth and 48.2% return on equity
Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Broadcom has a trailing twelve months EPS of $8.65.
PE Ratio
Broadcom has a trailing twelve months price to earnings ratio of 67.28. Meaning, the purchaser of the share is investing $67.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.2%.
Sales Growth
Broadcom’s sales growth is 15.4% for the ongoing quarter and 6% for the next.
Previous days news about Broadcom(AVGO)
- According to VentureBeat on Monday, 20 February, "Leading EPP platform vendors include Broadcom (Symantec), Bitdefender, CrowdStrike, Cisco, Cybereason, Deep Instinct, Trellix, Microsoft, SentinelOne, Sophos, Trend Micro and VMware Carbon Black."
